PATE-N inhibitors represent a fascinating class of chemical compounds that have garnered significant interest in the field of molecular biology and biochemistry. These inhibitors are primarily characterized by their ability to selectively bind and inhibit the activity of the PATE-N protein, a member of the prostate and testis expressed (PATE) family of proteins. The PATE family is known for its diverse roles in cellular processes, particularly in reproductive tissues. PATE-N, specifically, has been implicated in various cellular signaling pathways, making it a critical target for studying intracellular interactions and protein functions. The structural complexity of PATE-N inhibitors allows for specific and high-affinity interactions with their target protein, providing a robust tool for dissecting the biochemical pathways and molecular mechanisms regulated by PATE-N.
The design and synthesis of PATE-N inhibitors involve a multidisciplinary approach, combining insights from organic chemistry, structural biology, and computational modeling. These inhibitors often feature a core structure that mimics the natural ligands of PATE-N, allowing them to competitively bind to the protein's active site. Advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy have been instrumental in elucidating the binding interactions at an atomic level, revealing the key residues involved in the inhibition process. Furthermore, the development of PATE-N inhibitors is complemented by high-throughput screening methods and structure-activity relationship (SAR) studies, which enable the optimization of their binding properties and specificity. As a result, PATE-N inhibitors serve as invaluable tools for researchers aiming to uncover the physiological roles of PATE-N and its related signaling pathways, ultimately contributing to a deeper understanding of cellular function and molecular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
SRC family kinase inhibitor, may affect cell signaling pathways, possibly intersecting with PATE-N's role in cellular communication. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
BCR-ABL kinase inhibitor; could influence cell proliferation and survival pathways, potentially linked to PATE-N's function. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
BCL-2 inhibitor; might affect apoptotic pathways, potentially intersecting with PATE-N's role in cell survival mechanisms. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Bruton's tyrosine kinase inhibitor; could modify signaling pathways involved in cell growth, potentially related to PATE-N's activity. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
EGFR inhibitor; may influence cell proliferation and survival, possibly intersecting with PATE-N's role in these processes. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
mTOR inhibitor; could affect cell growth and survival pathways, potentially linked to PATE-N's function. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Tyrosine kinase inhibitor; might impact angiogenesis and growth factor signaling, potentially related to PATE-N. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor; could modify cell signaling pathways, possibly impacting PATE-N's function in cell growth and proliferation. | ||||||
XL-184 free base | 849217-68-1 | sc-364657 sc-364657A | 5 mg 10 mg | $94.00 $208.00 | 1 | |
MET and VEGFR2 inhibitor; might affect cell signaling and angiogenesis, potentially intersecting with PATE-N's role. | ||||||
Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $182.00 $661.00 $1690.00 | 3 | |
Multiple receptor tyrosine kinase inhibitor; could influence cell proliferation and angiogenesis pathways, possibly related to PATE-N. | ||||||